Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories - Bio-Rad Laboratories (NYSE:BIO)
4 Articles
4 Articles
The entry of the investor Elliott to the US laboratory supplier Bio-Rad ensures price gains at Sartorius. Investors speculate on strategic changes and a higher valuation.
Elliott takes activist stake in Bio-Rad
Elliott Investment Management has built a significant position in Bio-Rad Laboratories as part of a renewed push into the life sciences sector, according to a report by Bloomberg citing unnamed people familiar with the matter. The activist investor, which manages roughly $80bn in assets, is aiming to support a recovery in Bio-Rad’s share price following a prolonged period of weakness. The stock has fallen more than 70% from its peak in late 2021…
Activist investor Elliot is reportedly buying from Bio-Rad, which is likely to have consequences for Sartorius as well.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
